Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 15, 2007, Pages 4102-4106

  Lv, Jian ^a   Qian, Yunbo ^a   Liu, Tingting ^b   Wang, Yongmei ^a  

^a NANKAI UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Amphiphilic cationic; Antibacterial activity; MRSA; Quinine derived

Indexed keywords

AMPHOPHILE; QUININE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; CATIONS; DRUG EVALUATION, PRECLINICAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; QUININE; STAPHYLOCOCCUS AUREUS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 34447126353     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.05.065     Document Type: Article

References (21)

1. Grike S., Mohr K., and Schrape S. Biochem. Pharmacol. 38 (1989) 2487
2. Lüllmann H., and Mohr K. Drug Phospholipid Interactions. In: Gorrod J.W., Oelschläger H., and Caldwell J. (Eds). Metabolism of Xenobiotics (1988), Taylor & Francis, London
3. Hugo W.B., and Russel A.D. In: Russel A.D., Hugo W.B., and Ayliffe G.A.J. (Eds). Types of Antimicrobial Agents, Principles and Practice of Disinfection, Preservation. 2nd ed. (1992), Blackwell Scientific Publications Oxford, Oxford 7-68
4. Merianos J.J. Quaternary Ammonium Antimicrobial Compounds. In: Block S.S. (Ed). Disinfection, Sterilization, and Preservation. 4th ed. (1991), Lea and Febiger, Philadelphia 225-255
5. Ahlstrom B., Chelminska-Bertilsson M., Thompson R.A., and Edebo L. Antimicrob. Agents Chemother. 41 (1997) 544
6. Allenmark, S.; Lindstedt, M.; Edebo, L. U.S. Patent 5080902, 1992.
7. Wong Y.-L., Hubieki M.P., Curfaman C.L., Doncel G.F., Dudding T.C., Savle P.S., and Gandour R.D. Bioorg. Med. Chem. 10 (2002) 3599
8. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, MMWR. Moribid. Morial. Wkly. Rep. 2002, 51, 565.
9. Centers for Disease Control and Prevention. Public heath dispatch: vancomycin-resistant Staphylococcus aureus-Pennsylvania, MMWR. Moribid. Morial. Wkly. Rep. 2002, 51, 902.
10. Centers for Disease Control and Prevention. Four pediatric deaths. from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. MMWR. Morbid. Mortal. Wkly. Rep. 1999, 48, 707.
11. Okuma K., Iwakawa K., Turnidge J.D., Grubb W.B., Bell J.M., O'Brien F.G., Coombs G.W., Pearman J.W., Tenover F.C., Kapi M., Tiensasitorn C., Ito T., and Hiramatsu K. J. Clin. Microbiol. 40 (2002) 4289
12. Boelaert J.R., and Piette J. J. Clin. Virol. 20 (2001) 137
13. Wolf R., Tufano M.A., Ruocco V., Grimaldi E., Ruocco E., Donna-rumma G., and Baroni A. Int. J. Dermatol. 45 (2006) 661
14. Gul H.L., Denizci A.A., and Erciyas E. Arzneim.-Forsch. 52 (2002) 773
15. Rajabi L., Courreges C., Montoya J., Aguilera R.J., and Primm T.P. Lett. Appl. Microbiol. 40 (2005) 212
16. Miyazawa M., Shimamura H., and Nakamura S. J. Agric. Food Chem. 48 (2000) 4377
17. 6): 193.2, 159.0, 148.4, 148.2, 144.1, 140.9, 138.8, 132.3, 130.9, 128.5, 126.3, 124.2, 123.0, 119.9, 116.8, 101.5, 65.8, 62.8, 61.0, 57.9, 57.2, 56.8, 53.8,...
18. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Fifth Edition; Approved standard M7-A5. Wayne, PA: NCCLS; 2001.
19. 5cell/mL. The same inoculum was added to drug-free medium as a growth control. The test tubes were incubated in a water bath at 30 °C. Next, 100 μL of samples was taken from each tube at known time intervals, centrifuged, and washed three times with fresh Mueller-Hinton broth. After vortexed vigorously for 10 s, the suspension was suitably diluted and spread onto Mueller-Hinton agar plates. The plates were incubated at 30 °C for 24 h and colonies were counted. Each number of viable cells was determined from three-independent experiments performed in triplicate.
20. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Eighth Edition; Approved Standard M2-A8. Wayne, PA: NCCLS; 2003.
21. 9 cells/mL) was mixed with 0.1 mL of test substances at a series of concentrations (1-2000 μg/mL). The mixtures were incubated at 37 °C for 1 h. After incubation, tubes were centrifuged at 2000g for 10 min. The supernants were transferred into 96-well polystyrene plates (Costar 3590, incorporated) and the optical density was measured at 540 nm using MTP120 microplate reader (Colona Electric, Japan). The values for 0% and 100% lysis were determined by incubating erythrocytes with PBS, and 0.1% (v/v) Triton X-100 (Amresco 0694), respectively. Assays were carried out in triplicate and the results were confirmed in three-independent experiments.